{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T10:15:51Z","timestamp":1794996951514,"version":"4.9.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.cellsig.2026.112965","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:19:39Z","timestamp":1792718379000},"page":"112965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["WTAP\/YTHDC1-mediated m6A modification of P4HA1 suppresses hepatic gluconeogenesis and ameliorates MASLD by activating AKT signaling"],"prefix":"10.1016","volume":"150","author":[{"given":"Xia","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.cellsig.2026.112965_bb0005","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.cgh.2025.02.006","article-title":"High global prevalence of steatotic liver disease and associated subtypes: a meta-analysis","volume":"23","author":"Ho","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112965_bb0010","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cellsig.2026.112965_bb0015","article-title":"Advancements in pharmacological treatment of NAFLD\/MASLD: a focus on metabolic and liver-targeted interventions","volume":"12","author":"Ciardullo","year":"2024","journal-title":"Gastroenterol Rep (Oxf)."},{"key":"10.1016\/j.cellsig.2026.112965_bb0020","article-title":"NAFLD and nutraceuticals: a review of completed phase III and IV clinical trials","volume":"10","author":"Hegazi","year":"2023","journal-title":"Front. Med. (Lausanne)."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112965_bb0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12967-024-04872-x","article-title":"Hypoxia-induced P4HA1 overexpression promotes post-ischemic angiogenesis by enhancing endothelial glycolysis through downregulating FBP1","volume":"22","author":"Xu","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112965_bb0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12944-023-01911-2","article-title":"Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease","volume":"22","author":"Jiang","year":"2023","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.cellsig.2026.112965_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149180","article-title":"Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease","volume":"686","author":"Cao","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112965_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnves.2025.100023","article-title":"RNA m(6)A modification: a key regulator in normal and malignant processes","volume":"1","author":"Zhang","year":"2025","journal-title":"Cell Investig."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112965_bb0045","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/s41417-024-00789-1","article-title":"Regulatory roles of N6-methyladenosine (m(6)A) methylation in RNA processing and non-communicable diseases","volume":"31","author":"Khan","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.cellsig.2026.112965_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101700","article-title":"The epitranscriptome in ageing and stress resistance: a systematic review","volume":"81","author":"Wagner","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112965_bb0055","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1038\/s41467-022-32163-w","article-title":"Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112965_bb0060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13578-024-01293-7","article-title":"Reading the m(6)A-encoded epitranscriptomic information in development and diseases","volume":"14","author":"Chen","year":"2024","journal-title":"Cell Biosci."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112965_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0321757","article-title":"Integration of bioinformatics and identification of the role of m6A genes in NAFLD","volume":"20","author":"Ma","year":"2025","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112965_bb0070","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.7150\/ijbs.89942","article-title":"The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in Cancer","volume":"20","author":"Fontana","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cellsig.2026.112965_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216665","article-title":"Polo-like kinase 4 promotes tumorigenesis and glucose metabolism in glioma by activating AKT1 signaling","volume":"585","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2026.112965_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106569","article-title":"Phenolipid JE improves metabolic profile and inhibits gluconeogenesis via modulating AKT-mediated insulin signaling in STZ-induced diabetic mice","volume":"187","author":"Wang","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112965_bb0085","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.7150\/ijbs.68873","article-title":"Atractylenolide III ameliorates non-alcoholic fatty liver disease by activating hepatic adiponectin receptor 1-mediated AMPK pathway","volume":"18","author":"Li","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112965_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103910","article-title":"NAFLD and NASH: etiology, targets and emerging therapies","volume":"29","author":"Wei","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112965_bb0095","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S2468-1253(25)00300-0","article-title":"Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study","volume":"11","author":"Lazarus","year":"2026","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112965_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114492","article-title":"Glycolysis-related gene signatures and the functional role of P4HA1 in osteosarcoma prognosis","volume":"447","author":"Gui","year":"2025","journal-title":"Exp. Cell Res."},{"issue":"19","key":"10.1016\/j.cellsig.2026.112965_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26199371","article-title":"Enhanced collagen prolyl 4-hydroxylase activity and expression promote cancer progression via both canonical and non-canonical mechanisms","volume":"26","author":"Hironaka","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2026.112965_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00599","article-title":"Integrated analysis of multiple microarray studies to identify novel gene signatures in non-alcoholic fatty liver disease","volume":"10","author":"Jia","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112965_bb0115","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41419-025-07461-y","article-title":"Hypoxia-induced ATF3 escalates breast cancer invasion by increasing collagen deposition via P4HA1","volume":"16","author":"Dhamdhere","year":"2025","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112965_bb0120","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2174\/1574888X17666220827113434","article-title":"Prolyl 4-hydroxylase P4HA1 mediates the interplay between glucose metabolism and Stemness in pancreatic cancer cells","volume":"18","author":"Cao","year":"2023","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112965_bb0125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ccell.2025.01.005","article-title":"Mitochondrial succinate feeds T cell exhaustion in cancer","volume":"43","author":"Galluzzi","year":"2025","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112965_bb0130","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s00535-023-02008-4","article-title":"N6-methyladenosine RNA methylation in liver diseases: from mechanism to treatment","volume":"58","author":"Yang","year":"2023","journal-title":"J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112965_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/biom16010101","article-title":"N(6)-Methyladenosine (m(6)A)-mediated regulation of lipid metabolism: molecular mechanisms, pathological implications, and therapeutic perspectives","volume":"16","author":"Zhu","year":"2026","journal-title":"Biomolecules"},{"issue":"14","key":"10.1016\/j.cellsig.2026.112965_bb0140","doi-asserted-by":"crossref","DOI":"10.1172\/JCI177932","article-title":"Elevated WTAP promotes hyperinflammation by increasing m6A modification in inflammatory disease models","volume":"134","author":"Ge","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112965_bb0145","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2599543","article-title":"Helicobacter pylori infection aggravates hepatic steatosis by lactylation-driven WTAP-mediated m6a modification","volume":"17","author":"Chen","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.cellsig.2026.112965_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.gde.2024.102206","article-title":"The metabolic baton: conducting the dance of N6-methyladenosine writing and erasing","volume":"86","author":"Rabelo-Fern\u00e1ndez","year":"2024","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"Supplement_1","key":"10.1016\/j.cellsig.2026.112965_bb0155","doi-asserted-by":"crossref","DOI":"10.2337\/db25-210-OR","article-title":"210-OR: RNA binding protein YTHDC1 critically regulates liver metabolism and homeostasis","volume":"74","author":"Zheng","year":"2025","journal-title":"Diabetes"},{"issue":"35","key":"10.1016\/j.cellsig.2026.112965_bb0160","article-title":"YTHDC1 is essential for postnatal liver development and homeostasis","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci. (Weinh)."},{"issue":"20","key":"10.1016\/j.cellsig.2026.112965_bb0165","article-title":"Lactylation-driven YTHDC1 alleviates MASLD by suppressing PTPN22-mediated Dephosphorylation of NLRP3","volume":"13","author":"Zhang","year":"2026","journal-title":"Adv. Sci. (Weinh)."},{"key":"10.1016\/j.cellsig.2026.112965_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.139703","article-title":"AKT-FoxO1-PCK\/ChREBP signaling pathway regulates metabolic liver disease induced by high glucose in largemouth bass","volume":"295","author":"Li","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"17","key":"10.1016\/j.cellsig.2026.112965_bb0175","doi-asserted-by":"crossref","first-page":"E3940","DOI":"10.1073\/pnas.1716109115","article-title":"Conformational sampling of membranes by Akt controls its activation and inactivation","volume":"115","author":"Lu\u010di\u0107","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112965_bb0180","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41388-024-03224-9","article-title":"Unveiling RACK1: a key regulator of the PI3K\/AKT pathway in prostate cancer development","volume":"44","author":"Lyu","year":"2025","journal-title":"Oncogene"},{"issue":"33","key":"10.1016\/j.cellsig.2026.112965_bb0185","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101496118","article-title":"Structure of autoinhibited Akt1 reveals mechanism of PIP(3)-mediated activation","volume":"118","author":"Truebestein","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112965_bb0190","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1074\/jbc.M709585200","article-title":"Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt","volume":"283","author":"Kuo","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2026.112965_bb0195","article-title":"mTORC1-independent raptor prevents hepatic steatosis by stabilizing PHLPP2","volume":"7","author":"Kim","year":"2016","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.cellsig.2026.112965_bb0200","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.1074\/jbc.273.22.13375","article-title":"The tumor suppressor, PTEN\/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate","volume":"273","author":"Maehama","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112965_bb0205","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12964-023-01175-4","article-title":"Macrophage PTEN controls STING-induced inflammation and necroptosis through NICD\/NRF2 signaling in APAP-induced liver injury","volume":"21","author":"Yang","year":"2023","journal-title":"Cell Commun. Signal"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600625X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600625X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T09:16:57Z","timestamp":1794993417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682600625X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":41,"alternative-id":["S089865682600625X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112965","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WTAP\/YTHDC1-mediated m6A modification of P4HA1 suppresses hepatic gluconeogenesis and ameliorates MASLD by activating AKT signaling","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112965"}}